Bristol Myers Squibb (BMS)
A Bristol Myers Squibb (BMS) is a American multinational pharmaceutical company that is headquartered in New York City.
- Context:
- It can have Clinical Products, such as: Revlimid, Opdivo, and Eliquis.
- It can have Investigational Products, such as: Brivanib.
- …
- Example(s):
- Bristol Myers Squibb Research and Development (BMS-R&D) Department,
- BMS, 2021, with ~$46.4B total revenue.
- BMS, 2022, with ~39,709 employees.
- …
- Counter-Example(s):
- See: Cancer Treatment, Drug, Anticoagulant, Orencia, Sprycel, Yervoy, Celgene.
References
2022
- (Wikipedia, 2022) ⇒ https://en.wikipedia.org/wiki/Bristol_Myers_Squibb Retrieved:2022-7-13.
- The Bristol-Myers Squibb Company (BMS) is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2021, it had a total revenue of $46.4 billion.[1]
Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders.
BMS's primary research and development (R&D) sites are located in Lawrence, New Jersey (formerly Squibb, near Princeton), Summit, New Jersey, formerly HQ of Celgene, New Brunswick, New Jersey, Redwood City, California, and Seville in Spain, with other sites in Devens and Cambridge, Massachusetts, East Syracuse, New York, Braine-l'Alleud, Belgium, Tokyo, Japan, Bangalore, India, and Wirral, United Kingdom. BMS previously had an R&D site in Wallingford, Connecticut (formerly Bristol-Myers).
- The Bristol-Myers Squibb Company (BMS) is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2021, it had a total revenue of $46.4 billion.[1]
- ↑ "Bristol Myers Squibb 2021 Annual Report (Form 10-K)". SEC.gov. U.S. Securities and Exchange Commission. 9 February 2022.
2022b
- (Mikulic, 2022) ⇒ https://www.statista.com/statistics/266585/bristol-myers-squibbs-top-products-based-on-revenue/ Publshed by Matej Mikulic, Feb 10, 2022
- QUOTE: Bristol-Myers Squibb is a multinational pharmaceutical company headquartered in New York City. In 2021, their top products included Revlimid and Opdivo, drugs used in the treatment of certain cancers, and Eliquis, an anticoagulant. Those drugs generated 12.8, 10.8 and nearly seven billion dollars in revenue for the company, respectively. Other top drugs for the company included Orencia, Sprycel and Yervoy, to name a few. BMS announced in April 2019 and completed in November 2019 the acquisition of Celgene, thus making one of the largest pharma mega deals in the last years.